Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001470831-26-000388

Options or other derivatives

  • Chief Financial Officer acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Makhni Svetlana Ni · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-16 Grant or award : show line 1 in the form Stock Option (right to buy) +800,000 800,000 D
Loading xslF345X06/wk-form4_1776472005.xml…